Samsung and Galeon Collaborate for Progress in Healthcare AI Technology
Samsung has teamed up with Galeon, a Decentralized Science (DeSci) and health AI protocol, to enhance the training of artificial intelligence using data from Samsung’s ultrasound devices.
The partnership aims to improve medical AI without compromising patient privacy, supported by Tech Mahindra and Nvidia.
Galeon CEO Loïc Brotons announced that the EHR platform operates across 18 connected hospitals, including Rouen University Hospital, Caen University Hospital, Toulon Hospital, and Sud Francilien Hospital in France.
Galeon aims to create AI systems operating on a blockchain to enable on-chain computations with full traceability while anonymizing patient data, complying with privacy regulations. Brotons emphasized that hospitals retain control of their data while benefiting from AI training.
Training AI Without Storing Sensitive Data
The partnership allows healthcare providers to develop AI models without centralizing patient records, reducing privacy risks. Galeon has already developed tools for:
By leveraging AI improvements across multiple institutions, no medical information is divulged.
Also Read : SBI Shinsei Bank of Japan Partners with Partior & DeCurret on Tokenized Cross-Border Payments
Decentralized Science Facilitates Healthcare Advancement
Decentralized science (DeSci) is rapidly expanding in health research. VitaDAO awareness steward Alex Dobrin noted that the cost and time of drug development is pushing both researchers and investors toward decentralized models.
In May, HydraDAO, a decentralized research organization, reported experimental treatments where rats with transected spines regained mobility in five days, showcasing accelerated breakthroughs attracting investor interest.
Investors Support Healthcare DeSci Projects
Investment in DeSci platforms is increasing. Bio Protocol raised $6.9 million led by Maelstrom Fund and Animoca Brands, following previous investment from Binance Labs.
Access to key datasets is central to DeSci efforts. Competing platforms have attempted to acquire genetic and medical data, including 23andMe, which is reportedly facing bankruptcy.
The combination of decentralized science and AI is paving the way for privacy-sensitive, efficient medical research that drives innovation while protecting patients.
